Global Ophthalmoscopes Market Report 2023: Sector is Expected to Reach $408.7 Million by 2030 at a CAGR of 6.6%
June 02, 2023 04:43 ET
|
Research and Markets
Dublin, June 02, 2023 (GLOBE NEWSWIRE) -- The "Ophthalmoscopes Market Size, Share & Trends Analysis Report By Type (Direct, Indirect), By Application (Diabetic Retinopathy, Macular Degeneration,...
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
June 02, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, 2 June 2023. Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral,...
Dr. Kaustabh Ghosh Recognized With Prestigious Catalyst Award for Innovative Age-Related Macular Degeneration Research
June 01, 2023 09:06 ET
|
Doheny Eye Institute
PASADENA, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that Kaustabh Ghosh, PhD, was recently recognized by...
Kinarus Therapeutics Group Reports 2022 Annual Results
May 31, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Publishes Annual Report with Audited Consolidated Financial Results for Year Ended 31 December 2022Clinical efforts re-focused on developing KIN001 for original indications IPF and wet AMDCDIM CHF1.5...
Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management
May 11, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, May 10, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and...
Kinarus Therapeutics Reports Key Unaudited Full Year 2022 Figures
May 05, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Audited full year 2022 annual financial figures due to be reported by end of May 2023 Basel, Switzerland, May 5, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage...
Global Ophthalmic Drops Market Research Report 2023: Sector is Projected to Reach $1.9 Billion in 2030 at a CAGR of $7.09%
May 02, 2023 10:33 ET
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Ophthalmic Drops Market Research Report by Type (Over-the-counter Eye Drops, Prescription Eye Drops), Category (Anesthetic Drops, Antibiotic Drops,...
Kinarus Therapeutics Holding AG ("Kinarus") receives deadline extension from SER for publication of its 2022 annual financial report
April 28, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Ad hoc announcement pursuant to Art. 53 LR Kinarus Therapeutics Holding AG ("Kinarus") receives deadline extension from SER for publication of its 2022 annual financial report Basel, Switzerland, 28...
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2023 Annual Meeting
April 21, 2023 09:05 ET
|
Doheny Eye Institute
PASADENA, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that more than 30 of its scientists and...
Global Macular Degeneration Treatment Market Report 2023: Major Players Include Novartis, Bausch Health Companies, Regenxbio, F Hoffmann-La Roche and Regeneron Pharmaceuticals
March 23, 2023 11:03 ET
|
Research and Markets
Dublin, March 23, 2023 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...